Resultados globales: 4 registros encontrados en 0.02 segundos.
Artículos, Encontrados 4 registros
Artículos Encontrados 4 registros  
1.
12 p, 1.1 MB Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials / González-Gil, Celia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Lopes, Thaysa (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Fuster-Tormo, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; García-Chica, Jesús (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zhao, Ran (Cleveland Clinic) ; Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ; Torrent Catarineu, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Díaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ; Coll, Rosa (Institut Català d'Oncologia) ; Hermosín, Lourdes (Hospital de Jerez) ; Mercadal, Santiago (Hospital Duran i Reynals-ICO (Hospitalet del Llobregat)) ; González-Campos, José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Zamora, Lurdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Artola, Teresa (Hospital de Donostia (Sant Sebastià, País Basc)) ; Vall-Llovera, Ferran (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Tormo, Mar (Instituto de Investigación Sanitaria (València)) ; Gil-Cortés, Cristina (Hospital General de Alicante (Alicante)) ; Barba, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Novo, Andrés (Servicio Hospital Son Espases (Palma de Mallorca)) ; Ribera Salas, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bernal, Teresa (Hospital Universitario Central de Asturias) ; de Ugarriza, Paula López (Hospital Universitario Central de Asturias) ; Queipo, María-Paz (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Martínez-Sánchez, Pilar (Hospital Universitario 12 de Octubre (Madrid)) ; Giménez, Alicia (Hospital Universitario 12 de Octubre (Madrid)) ; González-Martínez, Teresa (Hospital Universitario de Salamanca) ; Cladera, Antonia (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Cervera, José (Hospital Universitari i Politècnic La Fe (València)) ; Fernández-Martín, Rosa (Hospital Universitario Insular de Gran Canaria) ; Ardaiz, María Ángeles (Complejo Hospitalario de Navarra) ; Vidal, María Jesús (Complejo Hospitalario de León) ; Baena, Ángela (Complejo Hospitalario de Jaén) ; López-Bigas, Nuria (Institut de Recerca Biomèdica (Barcelona)) ; Bigas Salvans, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Maciejewski, Jaroslaw (Taussig Cancer Institute) ; Orfao, Alberto (Universidad de Salamanca) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Genetic information has been crucial to understand the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) at diagnosis and at relapse, but still nowadays has a limited value in a clinical context. [...]
2022 - 10.3324/haematol.2022.281196
Haematologica, Vol. 108 (november 2022) , p. 969-980  
2.
14 p, 9.2 MB Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1 -Mutant Myelodysplastic Syndromes With Ringed Sideroblasts / Ademà, Vera (The University of Texas MD Anderson Cancer Center) ; Ma, Feiyang (University of Michigan) ; Kanagal-Shamanna, Rashmi (The University of Texas MD Anderson Cancer Center) ; Thongon, Natthakan (The University of Texas MD Anderson Cancer Center) ; Montalban-Bravo, Guillermo (The University of Texas) ; Yang, Hui (The University of Texas) ; Peslak, Scott A. (Children's Hospital of Philadelphia (Pennsilvània)) ; Wang, Feng (The University of Texas MD Anderson Cancer Center) ; Acha, Pamela (Universitat Autònoma de Barcelona) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Lockyer, Pamela (The University of Texas MD Anderson Cancer Center) ; Cassari, Margherita (University of Florence) ; Maciejewski, Jaroslaw P. (Cleveland Clinic Foundation) ; Visconte, Valeria (Cleveland Clinic Foundation) ; Gañán-Gómez, Irene (The University of Texas MD Anderson Cancer Center) ; Song, Yuanbin (Sun Yat-sen University Cancer Center) ; Bueso-Ramos, Carlos (The University of Texas MD Anderson Cancer Center) ; Pellegrini, Matteo (University of California) ; Tan, Tuyet M. (Univerity of California San Diego) ; Bejar, Rafael (Univerity of California San Diego) ; Carew, Jennifer S. (University of Arizona Cancer Center) ; Halene, Stephanie (Yale University School of Medicine) ; Santini, Valeria (University of Florence) ; Al-Atrash, Gheath (The University of Texas MD Anderson Cancer Center) ; Clise-Dwyer, Karen (The University of Texas MD Anderson Cancer Center) ; Garcia-Manero, Guillermo (The University of Texas MD Anderson Cancer Center) ; Blobel, Gerd A. (Children's Hospital of Philadelphia (Pennsilvània)) ; Colla, Simona (The University of Texas MD Anderson Cancer Center)
SF3B1 -mutant MDS-RS is associated with buildup of erythroid progenitor cells upregulating EIF2AK1-associated heme deficiency response and autophagy genes. Targeting EIF2AK1 relieves the dysregulated progenitor phenotype. [...]
2022 - 10.1158/2643-3230.BCD-21-0220
Blood Cancer Discovery, Vol. 3 (august 2022) , p. 554-567  
3.
13 p, 3.0 MB Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q / Ademà, Vera (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Walter, Wencke (Munich Leukemia Laboratory) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hutter, Stephan (Munich Leukemia Laboratory) ; La Framboise, Thomas (Department of Genetics and Genome Sciences. Case Western Reserve University) ; Arenillas, Leonor (Institut Hospital del Mar d'Investigacions Mèdiques) ; Meggendorfer, Manja (Munich Leukemia Laboratory) ; Radivoyevitch, Tomas (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pellagatti, Andrea (Blood Cancer UK Molecular Haematology Unit. Nuffield Division of Clinical Laboratory Sciences. Radcliffe Department of Medicine. University of Oxford and Oxford BRC Haematology Theme) ; Haferlach, Claudia (Munich Leukemia Laboratory) ; Boultwood, Jacqueline (University of Oxford. Radcliffe Department of Medicine) ; Kern, Wolfgang (Munich Leukemia Laboratory) ; Visconte, Valeria (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute) ; Sekeres, Mikkael (Leukemia Program. Department of Hematology and Medical Oncology. Cleveland Clinic. Cleveland Clinic Taussig Cancer Institute) ; Barnard, John (Department of Quantitative Health Sciences. Cleveland Clinic. Lerner Research Institute) ; Haferlach, Torsten (Munich Leukemia Laboratory) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Maciejewski, Jaroslaw (Department of Translational Hematology and Oncology Research. Lerner Research Institute. Cleveland Clinic. Taussig Cancer Institute)
Background: Haploinsufficiency (HI) resulting from deletion of the long arm of chromosome 5 [del(5q)] and the accompanied loss of heterozygosity are likely key pathogenic factors in del(5q) myeloid neoplasia (MN) although the consequences of del(5q) have not been yet clarified. [...]
2022 - 10.1016/j.ebiom.2022.104059
EBioMedicine, Vol. 80 (june 2022) , art. 104059  
4.
9 p, 1.4 MB TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes / McGraw, Kathy L. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Cluzeau, Thomas (Centre Hospitalier Universitaire de Nice (França)) ; Sallman, David A. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Basiorka, Ashley A. (University of South Florida (Estats Units d'Amèrica)) ; Irvine, Brittany A. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Ling, Zhang (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Epling-Burnette, P. K. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Rollison, Dana E. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sokol, Lubomir (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica)) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Maciejewski, Jaroslaw (Taussig Cancer Institute (Cleveland, Estats Units d'Amèrica)) ; List, Alan F. (Moffitt Cancer Center and Research Institute (Florida, Estats Units d'Amèrica))
Abstract:P53 is a key regulator of many cellular processes and is negatively regulated by the human homolog of murine double minute-2 (MDM2) E3 ubiquitin ligase. Single nucleotide polymorphisms (SNPs) of either gene alone, and in combination, are linked to cancer susceptibility, disease progression, and therapy response. [...]
2015 - 10.18632/oncotarget.5255
Oncotarget, Vol. 6 Núm. 33 (october 2015)  

Vea también: autores con nombres similares
1 Maciejewski, J. P.
1 Maciejewski, J.P.
1 Maciejewski, Jaroslaw P.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.